VivoSeq
Other

Blood Pressure

0

Pipeline Programs

13

Active Trials

25

Companies Involved

Blood Pressure is an early-stage landscape with 0 programs across 25 companies. The most active players are Merck & Co., Boehringer Ingelheim, Bayer.

Pipeline Metrics

Competitive Density

30/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

87/100

Attrition Rate

10/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

181

clinical trials

Completed125 · 69%
Unknown status24 · 13%
Terminated11 · 6%
Withdrawn8 · 4%
Recruiting5 · 3%
Active, not recruiting4 · 2%
Other4 · 2%

Trial Activity

181 trials

Synthetic THC And Blood Pressure
Not yet recruiting·MMayo Clinic·Phase 2/3·NCT07231965·50 enrolled
Page 1 of 13

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)